Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience
Pediatric Blood & Cancer2016Vol. 63(11), pp. 1974–1982
Citations Over TimeTop 10% of 2016 papers
Jonathan M. Marron, Steven G. DuBois, Julia Glade Bender, AeRang Kim, Brian D. Crompton, Stephanie Meyer, Katherine A. Janeway, Jennifer W. Mack
Abstract
Participants in pediatric GTP research perceive benefits of GTP to themselves and others, but expectations of personal benefits of GTP may exceed actual positive impact. These issues warrant consideration during consent discussions about GTP research participation.
Related Papers
- → UICC/CRC conference on targeted cancer therapy(1993)6 cited
- → The future of pediatric cancer and complex diseases: Aren't they all?(2007)2 cited
- Fast antibiotics reduce PICU needs, mortality of pediatric cancer patients(2015)
- Proper Timing of Apply Molecular-targeted Therapy(2014)
- → Advances in the Combination Therapy of Targeted Anti-Cancer Drugs(2016)